Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- Gestational diabetes and some of its treatments pose long-term risks to mothers, children Jennifer R. Southall
-
- Adults with growth hormone deficiency have higher medical costs, more comorbidities Michael Monostra
- COVID-19 vaccination does not alter thyroid function in adults with hypothyroidism Michael Monostra
- Experts debate obesity vs. glycemic control as primary target for treating type 2 diabetes Michael Monostra
- FDA lifts clinical hold on trial for novel stem cell-derived therapy for type 1 diabetes
- Greater fracture risk seen with insulin vs. metformin use for adults with type 2 diabetes Jill Rollet
- Growth hormone reduces liver fat, inflammation in adults with NAFLD Michael Monostra
- In type 2 diabetes, ‘something brain-friendly’ about GLP-1 receptor agonists Regina Schaffer
- Nonsteroidal MRAs ‘save lives’ in diabetes with cardiorenal disease Regina Schaffer
-
- Precision medicine app can help improve individualized treatment, diabetes outcomes Regina Schaffer
- Start early to treat risk factors in ‘pre-prediabetes,’ reduce complications Regina Schaffer
- VIDEO: Experts debate drivers of PCOS Andrea Dunaif, MD
- VIDEO: Surgery maintains role in treatment of diabetes despite new drugs Sangeeta Kashyap, MD
- What traditional Indian medicine teaches about eating well with diabetes Susan Weiner, MS, RDN, CDN, CDCES, FADCES
- Should drug therapy be used to reduce cardiometabolic risk from gestational diabetes?